Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC

British Columbia Cancer Agency · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
lung cancer non-small cell stage iv, brain metastases, egfr positive, osimertinib, srs, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 811997
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.